Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Clinical trial NCT01710644 · COMPLETED
Trial details
- NCT number
- NCT01710644
- Sponsor
- Nordmark Arzneimittel GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-07-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.